terbutaline has been researched along with Tremor in 66 studies
Terbutaline: A selective beta-2 adrenergic agonist used as a bronchodilator and tocolytic.
terbutaline : A member of the class of phenylethanolamines that is catechol substituted at position 5 by a 2-(tert-butylamino)-1-hydroxyethyl group.
Tremor: Cyclical movement of a body part that can represent either a physiologic process or a manifestation of disease. Intention or action tremor, a common manifestation of CEREBELLAR DISEASES, is aggravated by movement. In contrast, resting tremor is maximal when there is no attempt at voluntary movement, and occurs as a relatively frequent manifestation of PARKINSON DISEASE.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The bronchodilator, cardiovascular, and tremorigenic responses following administration of salbutamol (SAL), terbutaline (TER) and fenoterol (FEN) by closed-port intermittent nebulization were compared for a period of 8 hr." | 9.08 | Efficacy and side effects of beta 2-agonists by inhaled route in acute asthma in children: comparison of salbutamol, terbutaline, and fenoterol. ( Naspitz, CK; Scalabrin, DM; Solé, D, 1996) |
| " In order to investigate the possibility of replacing established treatment modalities with bambuterol once daily, we wanted to compare the bronchodilating and tremorogenic effects of bambuterol, 10 mg once daily, and terbutaline, 5 mg controlled-release (CR) tablets twice daily." | 9.07 | Therapeutic equivalence between bambuterol, 10 mg once daily, and terbutaline controlled release, 5 mg twice daily, in mild to moderate asthma. ( Fugleholm, AM; Ibsen, TB; Laxmyr, L; Svendsen, UG, 1993) |
| "The study was designed to compare terbutaline inhaled via a 750 ml spacer (Nebuhaler) with subcutaneous adrenaline injection as a first-line treatment for acute severe asthma." | 9.06 | Terbutaline pressurised aerosol inhaled via a Nebuhaler--an effective alternative to subcutaneous adrenaline for treatment of acute severe asthma. ( Charoenratanakul, S; Youngchaiyud, P, 1987) |
| "In a group of ten patients with chronic asthmatic bronchitis, a good improvement of the lung function was achieved by a sustained-release terbutaline preparation (Bricanyl Retard) in a dosage of 5 mg twice daily." | 9.06 | Terbutaline sustained-release treatment during one week 5 mg b.i.d. compared to one week placebo: terbutaline plasma levels, c-AMP plasma levels, lung function and tremor measurement. ( Drost, RH; Fokkens, JK; Hamelink, ML; Kreukniet, J; Maes, RA; van der Vet, AP, 1987) |
| "In a group of ten patients with chronic asthmatic bronchitis, the effect of monotherapy with theophylline and terbutaline and the combination of both drugs, as sustained-release tablets, was compared to placebo, in a double-blind cross-over, triple dummy at random study." | 9.06 | Combination therapy of theophylline and terbutaline as sustained-release preparations in patients with asthmatic bronchitis. ( Fokkens, JK; Hamelink, MJ; Kreukniet, J; Maes, RA; van der Vet, AP; van Drost, RH, 1987) |
| "5 mg) combined with 280 mg anhydrous theophylline orally in the randomized, double-blind, cross-over study in eight asthmatics." | 9.05 | Effects of oral theophylline combined with oral and inhaled beta-2-adrenostimulants in asthmatics. ( Svedmyr, K, 1982) |
| "To study the cardioselectivity of xamoterol, eight asthmatic patients took part in a randomised, double-blind, cross-over study, in which xamoterol or saline were infused, followed by four increasing doses of terbutaline i." | 9.05 | Effects of xamoterol (ICI 118,587) in asthmatic patients. ( Löfdahl, CG; Svedmyr, N, 1984) |
| "In 8 asthmatic subjects, serum concentrations of terbutaline were correlated with changes in volume of air expelled in the first second of forced expiration (FEV1), other parameters of lung function, c-AMP plasma concentrations and finger tremor values after administration of either 5 mg terbutaline sulphate orally, 0." | 9.05 | The effects of oral and subcutaneous administration of terbutaline in asthmatic patients. ( Bruynzeel, PL; Fokkens, JK; Kreukniet, J; Leferink, JG; Maes, RA; van den Berg, W, 1984) |
| "Procaterol, a new beta-2 adrenoceptor stimulant, was studied in a double-blind, placebo-controlled, cross-over trial in patients with bronchial asthma." | 9.05 | Procaterol and terbutaline in bronchial asthma. A double-blind, placebo-controlled, cross-over study. ( Dahl, R; Harving, H; Henriksen, J; Rønne, K; Schøler, P, 1985) |
| "Objective and subjective postural tremor responses at 60 and 120 min after drug treatment were studied in 24 veterans with chronic obstructive pulmonary disease who received either 5 mg terbutaline, 20 mg metaproterenol, or a placebo in random order." | 9.05 | Objective and subjective tremor responses to oral beta 2 agents on first exposure. A comparison of metaproterenol and terbutaline. ( Druz, WS; Jenne, JW; Marcucci, RA; Ridley, DJ; Rook, JC, 1982) |
| "The bioavailability of three different theophylline tablets (microcrystallinic theophylline, Theolair, Nuelin, 3M Riker), choline theophyllinate as a new film-coated tablet (Teovent, Ferrosan, Sweden) and theophyllaminopropanol (Oxyphylline, Draco, Sweden) was investigated in eight adult asthmatics and a randomized, double-blind, cross-over study." | 9.05 | Bioavailability of theophylline from three different tablets in asthmatic patients and their bronchodilating effects in combination with terbutaline inhalation. ( Mellstrand, T; Svedmyr, K; Svedmyr, N, 1982) |
| "Bronchodilation and side effects of 28 days treatment with either a full therapeutic dose of theophylline slow-release preparation 500 mg twice daily (400-600 mg), a slow-release terbutaline preparation 10 mg twice daily or combinations of the 2 drugs in full or half doses were evaluated in 31 asthmatic outpatients in a double-blind, randomized crossover design." | 9.05 | Long-term oral therapy of asthma with terbutaline and theophylline, alone and combined. ( Gnosspelius, Y; Gymose, E; Laursen, LC; Taudorf, E; Weeke, B, 1985) |
| "A double-blind crossover trial was conducted in 10 asthmatic patients for comparison of fenoterol with salbutamol, in 12 other asthmatic patients for comparison of reproterol with salbutamol, and in 15 other asthmatic patients for comparison of terbutaline with salbutamol." | 9.04 | [The bronchospasmolytics salbutamol, fenoterol, terbutaline and reproterol. Their effects and side effects in asthmatics after inhalation with an electric nebulizer]. ( Budmiger, H; Kyd, K; Scherrer, M, 1978) |
| "In a double-blind, single-dose trial asthmatic children, ages two to six years, received 25, 50 or 100 ug/kg terbutaline and placebo on four consecutive days." | 9.04 | Terbutaline elixir in preschool children with chronic asthma. ( Archer, JW; Pagtakhan, RD; Pizey, DM; Simons, FE, 1979) |
| "The effects of the selective beta2-receptor stimulator terbutaline (0-25 to 0-5 mg given intravenously) on myometrial activity, local uterine blood flow, and lower abdominal pain were examined during the first day of menstruation in 11 women with severe primary dysmenorrhoea." | 9.04 | Effects of terbutaline on myometrial activity, uterine blood flow, and lower abdominal pain in women with primary dysmenorrhoea. ( Akerlund, M; Andersson, KE; Ingemarsson, I, 1976) |
| "A group of 10 patients with chronic asthmatic bronchitis was titrated with slow-release theophylline (Theolin Retard) to a steady state plasma theophylline level of 10 mg/l." | 7.67 | Pharmacodynamics (lung function tests, tremor measurements and cAMP determinations) of a single dose of 0.5 mg terbutaline subcutaneously during sustained-release theophylline medication in patients with asthmatic bronchitis. ( Drost, RH; Fokkens, JK; Hamelink, ML; Kreukniet, J; Maes, RA; van der Vet, AP, 1986) |
| "Oral terbutaline in gradually increasing doses from 45 to 166 micrograms/kg three times daily was administered to asthmatic school children." | 7.67 | Dose, plasma concentration, and effect of oral terbutaline in long-term treatment of childhood asthma. ( Foucard, T; Lindström, B; Lönnerholm, G, 1984) |
| "Repeated finger tremor measurements have been performed in six normal and eight asthmatic subjects after subcutaneous and oral administration of terbutaline." | 7.66 | Tremor measurement in asthma. II. Changes after terbutaline administration suggesting beta-adrenergic blockade. ( Bruynzeel, PL; Fokkens, J; Kreukniet, J; Leferink, JG; Maes, RA; van den Berg, W, 1982) |
| "The bronchodilating properties and side effects of theophylline and a beta 2-adrenoceptor stimulating drug (terbutaline) alone and in combination were studied in 10 adult asthmatic patients." | 7.66 | Separate and combined use of terbutaline and theophylline in asthmatics. Effects related to plasma levels. ( Billing, B; Dahlqvist, R; Garle, M; Hörnblad, Y; Ripe, E, 1982) |
| "Enprofylline is a novel xanthine derivative with negligible adenosine antagonizing ability." | 6.66 | Additive bronchodilator effects of terbutaline and enprofylline in asthma. ( Lunell, E; Rasmussen, JB, 1987) |
| "Tremor was recorded with a 3-dimensional accelerometer during three different states of hand extensor muscle activity: relaxed, lightly and maximally contracted." | 6.66 | Induction and reduction of muscle tremor upon acute and repeated administration of the beta 2-agonists terbutaline, salbutamol and tulobuterol. ( Reeh, PW; Schaffler, K, 1987) |
| " Then after a further 3 wk of dosing 3 times a day of the second medication (10 patients received each medication), they were challenged once more 16 h after the last dose." | 6.66 | Comparison of tremor responses to orally administered albuterol and terbutaline. ( Druz, WS; Jenne, JW; Shaughnessy, TK; Starkey, PW; Valcarenghi, G; Yu, C, 1986) |
| "25 mg/puff) when administered as metered aerosol in a dosage of one puff followed by two puffs 30 min later produced the same maximum improvement of ventilatory function." | 6.64 | Hexoprenaline and terbutaline administered by inhalation. A comparison between two beta2-adrenoreceptor agonists with respect to effect on bronchial obstruction, heart rate, blood pressure and muscle tremor. ( Hörnblad, Y; Leideman, T; Ripe, E, 1978) |
| " The receptors were tested by infusion of increasing doses of isoprenaline, so that dose-response curves for isoprenaline were recorded." | 5.26 | Lack of bronchial beta adrenoceptor resistance in asthmatics during long-term treatment with terbutaline. ( Larsson, S; Svedmyr, N; Thiringer, G, 1977) |
| " Tachycardia is a side effect which limits dosage in a few patients only." | 5.26 | Comparison of infused and inhaled terbutaline in patients with asthma. ( Svedmyr, N; Thiringer, G, 1976) |
| " The bronchodilator, cardiovascular, and tremorigenic responses following administration of salbutamol (SAL), terbutaline (TER) and fenoterol (FEN) by closed-port intermittent nebulization were compared for a period of 8 hr." | 5.08 | Efficacy and side effects of beta 2-agonists by inhaled route in acute asthma in children: comparison of salbutamol, terbutaline, and fenoterol. ( Naspitz, CK; Scalabrin, DM; Solé, D, 1996) |
| " In order to investigate the possibility of replacing established treatment modalities with bambuterol once daily, we wanted to compare the bronchodilating and tremorogenic effects of bambuterol, 10 mg once daily, and terbutaline, 5 mg controlled-release (CR) tablets twice daily." | 5.07 | Therapeutic equivalence between bambuterol, 10 mg once daily, and terbutaline controlled release, 5 mg twice daily, in mild to moderate asthma. ( Fugleholm, AM; Ibsen, TB; Laxmyr, L; Svendsen, UG, 1993) |
| "In a group of ten patients with chronic asthmatic bronchitis, the effect of monotherapy with theophylline and terbutaline and the combination of both drugs, as sustained-release tablets, was compared to placebo, in a double-blind cross-over, triple dummy at random study." | 5.06 | Combination therapy of theophylline and terbutaline as sustained-release preparations in patients with asthmatic bronchitis. ( Fokkens, JK; Hamelink, MJ; Kreukniet, J; Maes, RA; van der Vet, AP; van Drost, RH, 1987) |
| "The study was designed to compare terbutaline inhaled via a 750 ml spacer (Nebuhaler) with subcutaneous adrenaline injection as a first-line treatment for acute severe asthma." | 5.06 | Terbutaline pressurised aerosol inhaled via a Nebuhaler--an effective alternative to subcutaneous adrenaline for treatment of acute severe asthma. ( Charoenratanakul, S; Youngchaiyud, P, 1987) |
| "In a group of ten patients with chronic asthmatic bronchitis, a good improvement of the lung function was achieved by a sustained-release terbutaline preparation (Bricanyl Retard) in a dosage of 5 mg twice daily." | 5.06 | Terbutaline sustained-release treatment during one week 5 mg b.i.d. compared to one week placebo: terbutaline plasma levels, c-AMP plasma levels, lung function and tremor measurement. ( Drost, RH; Fokkens, JK; Hamelink, ML; Kreukniet, J; Maes, RA; van der Vet, AP, 1987) |
| "The effects on baseline ventilation as well as beta 2-receptor stimulant-induced bronchodilation and tremor of atenolol and dilevalol, a beta-blocking agent with non-selective beta-antagonistic properties and intrinsic activity on the beta 2-receptor were evaluated in 8 patients with stable asthma." | 5.06 | Effects of dilevalol, a beta-adrenoceptor antagonist with intrinsic sympathetic activity in asthmatic patients. ( Hedner, J; Lemne, C; Svedmyr, N; Ullman, A, 1989) |
| "The influence of pretreatment with equipment bronchodilating doses of intravenous theophyllamine and inhaled terbutaline on the effect of five terbutaline inhalations was investigated in a cross-over study in six adult asthmatics with stable and reproducible bronchoconstriction." | 5.05 | Does theophylline potentiate inhaled beta 2-agonists? ( Svedmyr, K; Svedmyr, N, 1982) |
| "5 mg) combined with 280 mg anhydrous theophylline orally in the randomized, double-blind, cross-over study in eight asthmatics." | 5.05 | Effects of oral theophylline combined with oral and inhaled beta-2-adrenostimulants in asthmatics. ( Svedmyr, K, 1982) |
| "Bronchodilation and side effects of 28 days treatment with either a full therapeutic dose of theophylline slow-release preparation 500 mg twice daily (400-600 mg), a slow-release terbutaline preparation 10 mg twice daily or combinations of the 2 drugs in full or half doses were evaluated in 31 asthmatic outpatients in a double-blind, randomized crossover design." | 5.05 | Long-term oral therapy of asthma with terbutaline and theophylline, alone and combined. ( Gnosspelius, Y; Gymose, E; Laursen, LC; Taudorf, E; Weeke, B, 1985) |
| "The bioavailability of three different theophylline tablets (microcrystallinic theophylline, Theolair, Nuelin, 3M Riker), choline theophyllinate as a new film-coated tablet (Teovent, Ferrosan, Sweden) and theophyllaminopropanol (Oxyphylline, Draco, Sweden) was investigated in eight adult asthmatics and a randomized, double-blind, cross-over study." | 5.05 | Bioavailability of theophylline from three different tablets in asthmatic patients and their bronchodilating effects in combination with terbutaline inhalation. ( Mellstrand, T; Svedmyr, K; Svedmyr, N, 1982) |
| "Objective and subjective postural tremor responses at 60 and 120 min after drug treatment were studied in 24 veterans with chronic obstructive pulmonary disease who received either 5 mg terbutaline, 20 mg metaproterenol, or a placebo in random order." | 5.05 | Objective and subjective tremor responses to oral beta 2 agents on first exposure. A comparison of metaproterenol and terbutaline. ( Druz, WS; Jenne, JW; Marcucci, RA; Ridley, DJ; Rook, JC, 1982) |
| "Procaterol, a new beta-2 adrenoceptor stimulant, was studied in a double-blind, placebo-controlled, cross-over trial in patients with bronchial asthma." | 5.05 | Procaterol and terbutaline in bronchial asthma. A double-blind, placebo-controlled, cross-over study. ( Dahl, R; Harving, H; Henriksen, J; Rønne, K; Schøler, P, 1985) |
| "In 8 asthmatic subjects, serum concentrations of terbutaline were correlated with changes in volume of air expelled in the first second of forced expiration (FEV1), other parameters of lung function, c-AMP plasma concentrations and finger tremor values after administration of either 5 mg terbutaline sulphate orally, 0." | 5.05 | The effects of oral and subcutaneous administration of terbutaline in asthmatic patients. ( Bruynzeel, PL; Fokkens, JK; Kreukniet, J; Leferink, JG; Maes, RA; van den Berg, W, 1984) |
| "To study the cardioselectivity of xamoterol, eight asthmatic patients took part in a randomised, double-blind, cross-over study, in which xamoterol or saline were infused, followed by four increasing doses of terbutaline i." | 5.05 | Effects of xamoterol (ICI 118,587) in asthmatic patients. ( Löfdahl, CG; Svedmyr, N, 1984) |
| "In a single-blind, crossover study 10 adult asthmatic patients received a theophylline-ephedrine combination tablet (theophylline 90 mg, ephedrine 16 mg and phenobarbital 25 mg in an immediate release layer and theophylline 90 mg and ephedrine 32 mg in a sustained release layer) twice daily or terbutaline 5 mg three times daily for two weeks." | 5.04 | A comparison of a theophylline-ephedrine combination with terbutaline. ( Alcala, JC; Bush, RK; Lee, TP; Smith, AM; Welling, PG, 1978) |
| "A double-blind crossover trial was conducted in 10 asthmatic patients for comparison of fenoterol with salbutamol, in 12 other asthmatic patients for comparison of reproterol with salbutamol, and in 15 other asthmatic patients for comparison of terbutaline with salbutamol." | 5.04 | [The bronchospasmolytics salbutamol, fenoterol, terbutaline and reproterol. Their effects and side effects in asthmatics after inhalation with an electric nebulizer]. ( Budmiger, H; Kyd, K; Scherrer, M, 1978) |
| "In a double-blind, single-dose trial asthmatic children, ages two to six years, received 25, 50 or 100 ug/kg terbutaline and placebo on four consecutive days." | 5.04 | Terbutaline elixir in preschool children with chronic asthma. ( Archer, JW; Pagtakhan, RD; Pizey, DM; Simons, FE, 1979) |
| "The effects of the selective beta2-receptor stimulator terbutaline (0-25 to 0-5 mg given intravenously) on myometrial activity, local uterine blood flow, and lower abdominal pain were examined during the first day of menstruation in 11 women with severe primary dysmenorrhoea." | 5.04 | Effects of terbutaline on myometrial activity, uterine blood flow, and lower abdominal pain in women with primary dysmenorrhoea. ( Akerlund, M; Andersson, KE; Ingemarsson, I, 1976) |
| "Oral terbutaline in gradually increasing doses from 45 to 166 micrograms/kg three times daily was administered to asthmatic school children." | 3.67 | Dose, plasma concentration, and effect of oral terbutaline in long-term treatment of childhood asthma. ( Foucard, T; Lindström, B; Lönnerholm, G, 1984) |
| "The bronchodilating effect and side-effects of theophylline and a beta 2-adrenoceptor stimulating drug (terbutaline) alone and in combination were studied in 10 adult asthmatic patients." | 3.67 | Simultaneous treatment with terbutaline and theophylline. ( Billing, B; Dahlqvist, R; Garle, M; Hörnblad, Y; Ripe, E, 1984) |
| "A group of 10 patients with chronic asthmatic bronchitis was titrated with slow-release theophylline (Theolin Retard) to a steady state plasma theophylline level of 10 mg/l." | 3.67 | Pharmacodynamics (lung function tests, tremor measurements and cAMP determinations) of a single dose of 0.5 mg terbutaline subcutaneously during sustained-release theophylline medication in patients with asthmatic bronchitis. ( Drost, RH; Fokkens, JK; Hamelink, ML; Kreukniet, J; Maes, RA; van der Vet, AP, 1986) |
| "The bronchodilating properties and side effects of theophylline and a beta 2-adrenoceptor stimulating drug (terbutaline) alone and in combination were studied in 10 adult asthmatic patients." | 3.66 | Separate and combined use of terbutaline and theophylline in asthmatics. Effects related to plasma levels. ( Billing, B; Dahlqvist, R; Garle, M; Hörnblad, Y; Ripe, E, 1982) |
| "Hand tremor, heart rate, and electrolyte, plasma (pl) insulin, blood (bl) glucose, and pl terbutaline levels were measured in 11 healthy men during infusion and oral administration of terbutaline." | 3.66 | Extrapulmonary effects of terbutaline during prolonged administration. ( Bengtsson, B; Fagerstrom, PO, 1982) |
| "Repeated finger tremor measurements have been performed in six normal and eight asthmatic subjects after subcutaneous and oral administration of terbutaline." | 3.66 | Tremor measurement in asthma. II. Changes after terbutaline administration suggesting beta-adrenergic blockade. ( Bruynzeel, PL; Fokkens, J; Kreukniet, J; Leferink, JG; Maes, RA; van den Berg, W, 1982) |
| "Tremor was recorded with a 3-dimensional accelerometer during three different states of hand extensor muscle activity: relaxed, lightly and maximally contracted." | 2.66 | Induction and reduction of muscle tremor upon acute and repeated administration of the beta 2-agonists terbutaline, salbutamol and tulobuterol. ( Reeh, PW; Schaffler, K, 1987) |
| "Enprofylline is a novel xanthine derivative with negligible adenosine antagonizing ability." | 2.66 | Additive bronchodilator effects of terbutaline and enprofylline in asthma. ( Lunell, E; Rasmussen, JB, 1987) |
| " Then after a further 3 wk of dosing 3 times a day of the second medication (10 patients received each medication), they were challenged once more 16 h after the last dose." | 2.66 | Comparison of tremor responses to orally administered albuterol and terbutaline. ( Druz, WS; Jenne, JW; Shaughnessy, TK; Starkey, PW; Valcarenghi, G; Yu, C, 1986) |
| "25 mg/puff) when administered as metered aerosol in a dosage of one puff followed by two puffs 30 min later produced the same maximum improvement of ventilatory function." | 2.64 | Hexoprenaline and terbutaline administered by inhalation. A comparison between two beta2-adrenoreceptor agonists with respect to effect on bronchial obstruction, heart rate, blood pressure and muscle tremor. ( Hörnblad, Y; Leideman, T; Ripe, E, 1978) |
| "Tremor was assessed by visual observation and by an objective method based on accelerometry." | 1.27 | Beta-adrenoceptor agonists do not cause tremor in the conscious rat. ( Almgren, O; Hallberg, H, 1985) |
| " Dose-response curves for both drugs for FEV, heart rate, blood pressure, and tremor were recorded." | 1.26 | Comparison of intravenous ibuterol (KWD 2058), a new bronchodilator, and terbutaline. ( Larsson, S; Svedmyr, N, 1977) |
| " Tachycardia is a side effect which limits dosage in a few patients only." | 1.26 | Comparison of infused and inhaled terbutaline in patients with asthma. ( Svedmyr, N; Thiringer, G, 1976) |
| " The receptors were tested by infusion of increasing doses of isoprenaline, so that dose-response curves for isoprenaline were recorded." | 1.26 | Lack of bronchial beta adrenoceptor resistance in asthmatics during long-term treatment with terbutaline. ( Larsson, S; Svedmyr, N; Thiringer, G, 1977) |
| "When tremor is related to heart rate in a single experiment a regression line is obtained." | 1.25 | Evaluation of skeletal muscle tremor due to bronchodilator agents. ( Svedmyr, N; Thiringer, G, 1975) |
| " No toxic effects of the drug have been found." | 1.25 | The therapeutic value of oral long-term treatment with terbutaline (Bricanyl) in asthma. A follow-up study of its efficacy and side effects. ( Formgren, H, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 56 (84.85) | 18.7374 |
| 1990's | 9 (13.64) | 18.2507 |
| 2000's | 1 (1.52) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lakie, MD | 1 |
| Hayes, NR | 1 |
| Combes, N | 1 |
| Langford, N | 1 |
| Pegelow, KO | 1 |
| Strandberg, K | 1 |
| Löfdahl, CG | 5 |
| Bengtsson, B | 4 |
| Svedmyr, K | 6 |
| Svedmyr, N | 17 |
| van den Berg, W | 3 |
| Leferink, JG | 3 |
| Fokkens, JK | 5 |
| Kreukniet, J | 6 |
| Maes, RA | 6 |
| Bruynzeel, PL | 4 |
| Fokkens, J | 1 |
| Andersson, P | 1 |
| Olsson, OA | 1 |
| Waldeck, B | 1 |
| Billing, B | 2 |
| Dahlqvist, R | 2 |
| Garle, M | 2 |
| Hörnblad, Y | 3 |
| Ripe, E | 3 |
| Lönnerholm, G | 1 |
| Foucard, T | 1 |
| Lindström, B | 1 |
| Jenne, JW | 2 |
| Ridley, DJ | 1 |
| Marcucci, RA | 1 |
| Druz, WS | 2 |
| Rook, JC | 1 |
| Shapiro, GG | 1 |
| McPhillips, JJ | 1 |
| Smith, K | 1 |
| Furukawa, CT | 1 |
| Pierson, WE | 1 |
| Bierman, CW | 1 |
| Fagerstrom, PO | 1 |
| Mellstrand, T | 1 |
| Lindgren, SB | 1 |
| Larsson, S | 6 |
| Jaeschke, R | 1 |
| Guyatt, GH | 1 |
| Willan, A | 1 |
| Cook, D | 1 |
| Harper, S | 1 |
| Morris, J | 1 |
| Ramsdale, H | 1 |
| Haddon, R | 1 |
| Newhouse, M | 1 |
| Fugleholm, AM | 1 |
| Ibsen, TB | 1 |
| Laxmyr, L | 1 |
| Svendsen, UG | 1 |
| Lyrenäs, E | 1 |
| Sand, C | 1 |
| Abrahamsson, H | 1 |
| Larsén, K | 1 |
| Schmekel, B | 1 |
| Scalabrin, DM | 1 |
| Solé, D | 1 |
| Naspitz, CK | 1 |
| Ekström, T | 1 |
| Ringdal, N | 1 |
| Tukiainen, P | 1 |
| Runnerström, E | 1 |
| Soliman, S | 1 |
| Cazzola, M | 1 |
| Calderaro, F | 1 |
| Califano, C | 1 |
| Di Pema, F | 1 |
| Vinciguerra, A | 1 |
| Donner, CF | 1 |
| Matera, MG | 1 |
| Schäfers, RF | 1 |
| Piest, U | 1 |
| von Birgelen, C | 1 |
| Jakubetz, J | 1 |
| Daul, AE | 1 |
| Philipp, T | 1 |
| Brodde, OE | 1 |
| Pinder, RM | 1 |
| Brogden, RN | 1 |
| Speight, TM | 1 |
| Avery, GS | 1 |
| Thiringer, G | 5 |
| Bush, RK | 1 |
| Smith, AM | 1 |
| Welling, PG | 1 |
| Alcala, JC | 1 |
| Lee, TP | 1 |
| Formgren, H | 2 |
| Bennis, J | 1 |
| Leideman, T | 1 |
| Simons, FE | 1 |
| Pizey, DM | 1 |
| Archer, JW | 1 |
| Pagtakhan, RD | 1 |
| Budmiger, H | 1 |
| Kyd, K | 1 |
| Scherrer, M | 1 |
| Akerlund, M | 1 |
| Andersson, KE | 1 |
| Ingemarsson, I | 1 |
| Lawyer, C | 1 |
| Pond, A | 1 |
| Lipworth, BJ | 1 |
| Clark, RA | 1 |
| Dhillon, DP | 1 |
| McDevitt, DG | 1 |
| Hedner, J | 1 |
| Ullman, A | 1 |
| Lemne, C | 1 |
| Laursen, LC | 1 |
| Taudorf, E | 1 |
| Gnosspelius, Y | 1 |
| Gymose, E | 1 |
| Weeke, B | 1 |
| van der Vet, AP | 3 |
| van Drost, RH | 1 |
| Hamelink, MJ | 1 |
| Drost, RH | 2 |
| Hamelink, ML | 2 |
| Hallberg, H | 1 |
| Almgren, O | 1 |
| Schaffler, K | 1 |
| Reeh, PW | 1 |
| Dahl, R | 1 |
| Harving, H | 1 |
| Henriksen, J | 1 |
| Rønne, K | 1 |
| Schøler, P | 1 |
| Logigian, EL | 1 |
| Wierzbicka, MM | 1 |
| Bruyninckx, F | 1 |
| Wiegner, AW | 1 |
| Shahahi, BT | 1 |
| Young, RR | 1 |
| Rasmussen, JB | 1 |
| Lunell, E | 1 |
| Youngchaiyud, P | 1 |
| Charoenratanakul, S | 1 |
| Hill, WC | 1 |
| Valcarenghi, G | 1 |
| Starkey, PW | 1 |
| Yu, C | 1 |
| Shaughnessy, TK | 1 |
| Simonsson, BG | 1 |
| Svedenblad, H | 1 |
| Axelsson, I | 1 |
| Andersson, AL | 1 |
| Richens, A | 1 |
| Watson, JM | 1 |
| Kingsley, PJ | 1 |
| Volans, GN | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A 12-week, Double-blind, Multicenter, 3-crossover, Placebo Controlled and Randomized Trial to Investigate the Efficacy and Safety of 10mg and 5mg Bambuterol Tablets Once Daily in Patients With Chronic Obstructive Pulmonary Disease (COPD)[NCT01796730] | Phase 4 | 60 participants (Actual) | Interventional | 2013-02-28 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for terbutaline and Tremor
| Article | Year |
|---|---|
Rimiterol: a review of its pharmacological properties and therapeutic efficacy in asthma.
Topics: Absorption; Administration, Oral; Aerosols; Albuterol; Animals; Asthma; Bronchodilator Agents; Catec | 1977 |
Long-term treatment with beta2-adrenostimulants in asthma. Side effects, selectivity, tolerance, and routes of administration.
Topics: Administration, Oral; Adrenergic beta-Agonists; Aerosols; Albuterol; Arrhythmias, Cardiac; Asthma; E | 1977 |
37 trials available for terbutaline and Tremor
| Article | Year |
|---|---|
Evaluation of the bronchodilating and antiallergic properties of a beta-adrenoceptor stimulant, KWD 2131, in asthmatic patients.
Topics: Adrenergic beta-Antagonists; Adult; Allergens; Asthma; Bronchodilator Agents; Chronic Disease; Clini | 1980 |
Two new beta 2-adrenoceptor agonists, D-2343 and QH 25, studied in asthmatic patients.
Topics: Adrenergic beta-Agonists; Adult; Aged; Albuterol; Animals; Asthma; Bronchodilator Agents; Depression | 1982 |
Does theophylline potentiate inhaled beta 2-agonists?
Topics: Administration, Intranasal; Administration, Oral; Adrenergic beta-Agonists; Asthma; Blood Pressure; | 1982 |
Effects of oral theophylline combined with oral and inhaled beta-2-adrenostimulants in asthmatics.
Topics: Administration, Intranasal; Administration, Oral; Adrenergic beta-Agonists; Adult; Aged; Asthma; Blo | 1982 |
Effect of prenalterol in asthmatic patients.
Topics: Adrenergic beta-Agonists; Aerosols; Aged; Asthma; Blood Pressure; Dose-Response Relationship, Drug; | 1982 |
Effects of xamoterol (ICI 118,587) in asthmatic patients.
Topics: Adrenergic beta-Agonists; Adult; Aged; Asthma; Blood Pressure; Female; Forced Expiratory Volume; Hum | 1984 |
The effects of oral and subcutaneous administration of terbutaline in asthmatic patients.
Topics: Administration, Oral; Adult; Asthma; Cyclic AMP; Forced Expiratory Volume; Humans; Injections, Subcu | 1984 |
A new beta 2-adrenoceptor agonist--D 2343--with long duration. Inhalation comparison with terbutaline in asthmatics.
Topics: Asthma; Heart Rate; Humans; Octopamine; Respiratory Function Tests; Respiratory Therapy; Terbutaline | 1984 |
Objective and subjective tremor responses to oral beta 2 agents on first exposure. A comparison of metaproterenol and terbutaline.
Topics: Administration, Oral; Aged; Clinical Trials as Topic; Double-Blind Method; Humans; Lung Diseases, Ob | 1982 |
Effectiveness of terbutaline and theophylline alone and in combination in exercise-induced bronchospasm.
Topics: Adolescent; Adult; Asthma; Asthma, Exercise-Induced; Child; Clinical Trials as Topic; Double-Blind M | 1981 |
Bioavailability of theophylline from three different tablets in asthmatic patients and their bronchodilating effects in combination with terbutaline inhalation.
Topics: Administration, Intranasal; Administration, Oral; Asthma; Biological Availability; Bronchodilator Ag | 1982 |
Effect of increasing doses of beta agonists on spirometric parameters, exercise capacity, and quality of life in patients with chronic airflow limitation.
Topics: Aged; Dose-Response Relationship, Drug; Double-Blind Method; Exercise Tolerance; Female; Humans; Lun | 1994 |
Therapeutic equivalence between bambuterol, 10 mg once daily, and terbutaline controlled release, 5 mg twice daily, in mild to moderate asthma.
Topics: Adolescent; Adult; Asthma; Bronchodilator Agents; Delayed-Action Preparations; Double-Blind Method; | 1993 |
Tremor in healthy volunteers after bambuterol and terbutaline CR-tablets.
Topics: Administration, Oral; Adult; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Male; | 1993 |
Efficacy and side effects of beta 2-agonists by inhaled route in acute asthma in children: comparison of salbutamol, terbutaline, and fenoterol.
Topics: Administration, Inhalation; Adolescent; Adrenergic beta-Agonists; Albuterol; Asthma; Bronchodilator | 1996 |
A 3-month comparison of formoterol with terbutaline via turbuhaler. A placebo-controlled study.
Topics: Administration, Inhalation; Adolescent; Adrenergic beta-Agonists; Adult; Aged; Aged, 80 and over; Br | 1998 |
Oral bambuterol compared to inhaled salmeterol in patients with partially reversible chronic obstructive pulmonary disease.
Topics: Administration, Inhalation; Administration, Oral; Adult; Aged; Albuterol; Arrhythmias, Cardiac; Bron | 1999 |
Disodium cromoglycate does not prevent terbutaline-induced desensitization of beta 2-adrenoceptor-mediated cardiovascular in vivo functions in human volunteers.
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Adult; Anti-Allergic Agents; Blood Pr | 1999 |
Rimiterol: a review of its pharmacological properties and therapeutic efficacy in asthma.
Topics: Absorption; Administration, Oral; Aerosols; Albuterol; Animals; Asthma; Bronchodilator Agents; Catec | 1977 |
A comparison of a theophylline-ephedrine combination with terbutaline.
Topics: Adult; Asthma; Clinical Trials as Topic; Cyclic AMP; Drug Combinations; Ephedrine; Humans; Lung; Ter | 1978 |
A controlled comparison of salbutamol and terbutaline inhaled by IPPV in asthmatic patients: a dose-response study.
Topics: Adult; Albuterol; Asthma; Bronchitis; Clinical Trials as Topic; Dose-Response Relationship, Drug; Do | 1977 |
Hexoprenaline and terbutaline administered by inhalation. A comparison between two beta2-adrenoreceptor agonists with respect to effect on bronchial obstruction, heart rate, blood pressure and muscle tremor.
Topics: Aerosols; Asthma; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; He | 1978 |
Terbutaline elixir in preschool children with chronic asthma.
Topics: Acute Disease; Asthma; Blood Pressure; Child; Child, Preschool; Chronic Disease; Dose-Response Relat | 1979 |
[The bronchospasmolytics salbutamol, fenoterol, terbutaline and reproterol. Their effects and side effects in asthmatics after inhalation with an electric nebulizer].
Topics: Adult; Aged; Albuterol; Asthma; Bronchodilator Agents; Female; Fenoterol; Humans; Hypoxia; Male; Met | 1978 |
Effects of terbutaline on myometrial activity, uterine blood flow, and lower abdominal pain in women with primary dysmenorrhoea.
Topics: Adult; Clinical Trials as Topic; Dysmenorrhea; Endometrium; Female; Heart Rate; Humans; Pain; Recept | 1976 |
Comparison of the effects of prolonged treatment with low and high doses of inhaled terbutaline on beta-adrenoceptor responsiveness in patients with chronic obstructive pulmonary disease.
Topics: Administration, Inhalation; Cyclic AMP; Dose-Response Relationship, Drug; Double-Blind Method; Elect | 1990 |
Effects of dilevalol, a beta-adrenoceptor antagonist with intrinsic sympathetic activity in asthmatic patients.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Asthma; Atenolol; Double-Blind Method; Female; Forced Expi | 1989 |
Long-term oral therapy of asthma with terbutaline and theophylline, alone and combined.
Topics: Administration, Oral; Adolescent; Adult; Aged; Akathisia, Drug-Induced; Arrhythmias, Cardiac; Asthma | 1985 |
Combination therapy of theophylline and terbutaline as sustained-release preparations in patients with asthmatic bronchitis.
Topics: Adult; Asthma; Cyclic AMP; Delayed-Action Preparations; Double-Blind Method; Drug Evaluation; Drug T | 1987 |
Terbutaline sustained-release treatment during one week 5 mg b.i.d. compared to one week placebo: terbutaline plasma levels, c-AMP plasma levels, lung function and tremor measurement.
Topics: Adult; Bronchitis; Cyclic AMP; Delayed-Action Preparations; Female; Forced Expiratory Volume; Humans | 1987 |
Induction and reduction of muscle tremor upon acute and repeated administration of the beta 2-agonists terbutaline, salbutamol and tulobuterol.
Topics: Adrenergic beta-Agonists; Adult; Albuterol; Blood Pressure; Electromyography; Heart Rate; Humans; Is | 1987 |
Procaterol and terbutaline in bronchial asthma. A double-blind, placebo-controlled, cross-over study.
Topics: Adolescent; Adult; Aged; Asthma; Clinical Trials as Topic; Double-Blind Method; Ethanolamines; Femal | 1985 |
Additive bronchodilator effects of terbutaline and enprofylline in asthma.
Topics: Adult; Aged; Asthma; Blood Pressure; Bronchodilator Agents; Drug Synergism; Female; Forced Expirator | 1987 |
Terbutaline pressurised aerosol inhaled via a Nebuhaler--an effective alternative to subcutaneous adrenaline for treatment of acute severe asthma.
Topics: Acute Disease; Adolescent; Adult; Aerosols; Asthma; Double-Blind Method; Dyspnea; Epinephrine; Femal | 1987 |
Comparison of tremor responses to orally administered albuterol and terbutaline.
Topics: Administration, Oral; Aged; Albuterol; Forced Expiratory Volume; Humans; Lung Diseases, Obstructive; | 1986 |
Proceedings: Effects of salbutamol and terbutaline on physiological tremor in man.
Topics: Albuterol; Bronchi; Dilatation; Fingers; Heart Rate; Humans; Muscle Contraction; Placebos; Stimulati | 1973 |
A comparison of the beta 1 and beta 2 effects of subcutaneous isoprenaline, sulbutamol and terbutaline in adult man.
Topics: Adult; Albuterol; Analysis of Variance; Bronchial Spasm; Dose-Response Relationship, Drug; Forearm; | 1974 |
28 other studies available for terbutaline and Tremor
| Article | Year |
|---|---|
Is postural tremor size controlled by interstitial potassium concentration in muscle?
Topics: Adrenergic beta-Agonists; Adult; Electromyography; Female; Humans; Ischemia; Male; Muscle, Skeletal; | 2004 |
Clinical implications of drug-induced desensitization of the beta receptor after continuous oral use of terbutaline.
Topics: Adult; Asthma; Cyclic AMP; Humans; Leukocytes; Lung Volume Measurements; Middle Aged; Receptors, Adr | 1982 |
Tremor measurement in asthma. II. Changes after terbutaline administration suggesting beta-adrenergic blockade.
Topics: Administration, Oral; Adult; Asthma; Cyclic AMP; Humans; Injections, Subcutaneous; Male; Middle Aged | 1982 |
Comparison of beta 2-adrenoceptor stimulation in bronchial and skeletal muscle in experimental and clinical studies.
Topics: Albuterol; Animals; Asthma; Bronchi; Cats; Guinea Pigs; Histamine; Humans; Muscle, Smooth; Muscles; | 1984 |
Changes in the beta-adrenergic system due to beta-adrenergic therapy: clinical consequences.
Topics: Adenine Nucleotides; Asthma; Desensitization, Immunologic; Forced Expiratory Volume; Humans; In Vitr | 1984 |
Plasma concentration and side-effects of terbutaline.
Topics: Adult; Blood Glucose; Calcium; Half-Life; Heart Rate; Humans; Insulin; Male; Potassium; Sodium; Terb | 1984 |
Simultaneous treatment with terbutaline and theophylline.
Topics: Adult; Aged; Asthma; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Female; Forced | 1984 |
Comparison of the effects of a new anticholinergic drug (AA 28-263, Sandoz) and terbutaline in a dose-response study in endogenous asthmatics.
Topics: Adult; Aerosols; Airway Resistance; Asthma; Blood Pressure; Dibenzothiepins; Dose-Response Relations | 1984 |
Dose, plasma concentration, and effect of oral terbutaline in long-term treatment of childhood asthma.
Topics: Administration, Oral; Adolescent; Asthma; Child; Dose-Response Relationship, Drug; Female; Heart Rat | 1984 |
Extrapulmonary effects of terbutaline during prolonged administration.
Topics: Adult; Blood Glucose; Electrolytes; Half-Life; Heart Rate; Humans; Insulin; Male; Terbutaline; Time | 1982 |
Separate and combined use of terbutaline and theophylline in asthmatics. Effects related to plasma levels.
Topics: Adult; Aged; Asthma; Dose-Response Relationship, Drug; Drug Interactions; Female; Forced Expiratory | 1982 |
Inhalation of terbutaline sulphate through a conventional actuator or a pear-shaped tube: effects and side effects.
Topics: Adult; Aerosols; Aged; Dose-Response Relationship, Drug; Female; Forced Expiratory Volume; Heart Rat | 1982 |
Inhibitory effects of terbutaline on human esophageal peristalsis and development of tolerance.
Topics: Administration, Oral; Drug Administration Schedule; Drug Tolerance; Esophagus; Fingers; Heart Rate; | 1993 |
Lack of bronchial beta adrenoceptor resistance in asthmatics during long-term treatment with terbutaline.
Topics: Adult; Asthma; Blood Pressure; Bronchi; Bronchial Spasm; Dose-Response Relationship, Drug; Drug Resi | 1977 |
Tremor caused by sympathomimetics is mediated by beta2-adrenoreceptors.
Topics: Blood Pressure; Heart Rate; Humans; Informed Consent; Metoprolol; Propranolol; Receptors, Adrenergic | 1977 |
Broncho-and cardioselective beta-receptor active drugs in the treatment of asthmatic patients. Clinical studies of effects and side effects of terbutaline, practolol and metoprolol.
Topics: Administration, Oral; Asthma; Bronchodilator Agents; Dose-Response Relationship, Drug; Drug Evaluati | 1977 |
Comparison of infused and inhaled terbutaline in patients with asthma.
Topics: Aerosols; Asthma; Drug Evaluation; Humans; Injections, Intravenous; Terbutaline; Tremor | 1977 |
Problems with terbutaline.
Topics: Administration, Oral; Aged; Female; Humans; Injections, Subcutaneous; Terbutaline; Tremor | 1977 |
Comparison of intravenous ibuterol (KWD 2058), a new bronchodilator, and terbutaline.
Topics: Adult; Blood Pressure; Bronchial Diseases; Bronchodilator Agents; Dose-Response Relationship, Drug; | 1977 |
Evaluation of skeletal muscle tremor due to bronchodilator agents.
Topics: Adult; Asthma; Blood Pressure; Bronchitis; Chronic Disease; Female; Heart Rate; Humans; Isoprotereno | 1975 |
The therapeutic value of oral long-term treatment with terbutaline (Bricanyl) in asthma. A follow-up study of its efficacy and side effects.
Topics: Administration, Oral; Adult; Aerosols; Aged; Blood Pressure; Chronic Disease; Drug Evaluation; Drug | 1975 |
Comparison of infused and inhaled terbutaline in patients with asthma.
Topics: Adult; Aerosols; Asthma; Blood Pressure; Dose-Response Relationship, Drug; Female; Heart Rate; Human | 1976 |
Beta-adrenoceptor agonists do not cause tremor in the conscious rat.
Topics: Adrenergic beta-Agonists; Animals; Isoproterenol; Male; Oxotremorine; Rats; Rats, Inbred Strains; Re | 1985 |
Motor unit synchronization in physiologic, enhanced physiologic, and voluntary tremor in man.
Topics: Electromyography; Humans; Motor Neurons; Muscle Spindles; Muscles; Signal Processing, Computer-Assis | 1988 |
Pharmacodynamics (lung function tests, tremor measurements and cAMP determinations) of a single dose of 0.5 mg terbutaline subcutaneously during sustained-release theophylline medication in patients with asthmatic bronchitis.
Topics: Adult; Asthma; Bronchitis; Cyclic AMP; Delayed-Action Preparations; Drug Interactions; Female; Human | 1986 |
Overdosage of subcutaneous terbutaline in the treatment of preterm labor.
Topics: Adolescent; Anxiety; Female; Humans; Obstetric Labor, Premature; Pregnancy; Tachycardia; Terbutaline | 1986 |
Systemic effects of inhalation of terbutaline with IPPB in normal subjects.
Topics: Adult; Aerosols; Blood Pressure; Carbon Dioxide; Depression, Chemical; Female; Heart Rate; Hemodynam | 1974 |
Letter: Studies of resistance to long-acting adrenergic beta-stimulators in asthmatic patients.
Topics: Asthma; Blood Pressure; Bronchi; Drug Resistance; Drug Tolerance; Heart Rate; Humans; Isoproterenol; | 1974 |